Ihuman Valuation
| IH Stock | USD 1.55 0.09 5.49% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Ihuman Inc retains a regular Real Value of $2.08 per share. The prevalent price of the firm is $1.55. Our model calculates the value of Ihuman Inc from evaluating the firm fundamentals such as Return On Equity of 0.15, current valuation of (69.71 M), and Return On Asset of 0.0456 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Ihuman's valuation include:
Price Book 0.684 | Enterprise Value -69.7 M | Enterprise Value Ebitda 0.7528 | Price Sales 0.0893 | Forward PE 58.1395 |
Undervalued
Today
Please note that Ihuman's price fluctuation is very risky at this time. Calculation of the real value of Ihuman Inc is based on 3 months time horizon. Increasing Ihuman's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ihuman is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ihuman Stock. However, Ihuman's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.55 | Real 2.08 | Target 3.78 | Hype 1.55 | Naive 1.54 |
The intrinsic value of Ihuman's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Ihuman's stock price.
Estimating the potential upside or downside of Ihuman Inc helps investors to forecast how Ihuman stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ihuman more accurately as focusing exclusively on Ihuman's fundamentals will not take into account other important factors: When choosing an evaluation method for Ihuman Inc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Ihuman Cash |
|
Ihuman Valuation Trend
Ihuman's real value analysis enables investors to forecast the earnings more efficiently. Using both Ihuman's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Ihuman Total Value Analysis
Ihuman Inc is currently forecasted to have takeover value of (69.71 M) with market capitalization of 85.89 M, debt of 3.86 M, and cash on hands of 1.05 B. The negative valuation of Ihuman may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding debt commitments of the company both on and off balance sheet. Investors should methodically examine all of the Ihuman fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(69.71 M) | 85.89 M | 3.86 M | 1.05 B |
Ihuman Investor Information
The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ihuman Inc recorded a loss per share of 0.16. The entity last dividend was issued on the 27th of March 2024. Based on the analysis of Ihuman's profitability, liquidity, and operating efficiency, Ihuman Inc is doing better financially today then in previous quarter. It has a moderate chance of reporting better financial numbers in December.Ihuman Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ihuman has an asset utilization ratio of 70.19 percent. This signifies that the Company is making $0.7 for each dollar of assets. An increasing asset utilization means that Ihuman Inc is more efficient with each dollar of assets it utilizes for everyday operations.Ihuman Ownership Allocation
Ihuman Inc has a total of 23.57 Million outstanding shares. Roughly 99.39 (percent) of Ihuman outstanding shares are held by general public with 0.61 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Ihuman Profitability Analysis
The company generated the yearly revenue of 1.02 B. Reported Net Income was 180.91 M with gross profit of 660.62 M.Ihuman Past Distributions to stockholders
About Ihuman Valuation
An absolute valuation paradigm, as applied to Ihuman Stock, attempts to find the value of Ihuman Inc based on its fundamental and basic technical indicators. By analyzing Ihuman's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Ihuman's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ihuman. We calculate exposure to Ihuman's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ihuman's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 721.3 M | 483.8 M | |
| Pretax Profit Margin | 0.20 | 0.21 | |
| Operating Profit Margin | 0.16 | 0.16 | |
| Net Profit Margin | 0.18 | 0.19 | |
| Gross Profit Margin | 0.71 | 0.52 |
A single share of Ihuman represents a small ownership stake in the entity. As a stockholder of Ihuman, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Ihuman Dividends Analysis For Valuation
Please note that Ihuman has scaled down on payment of dividends at this time. As of now, Ihuman's Earnings Yield is increasing as compared to previous years. The Ihuman's current Price Earnings Ratio is estimated to increase to 7.07, while Retained Earnings are projected to decrease to (147.5 M).
There are various types of dividends Ihuman can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Ihuman shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Ihuman Inc directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Ihuman pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Ihuman by the value of the dividends paid out.
Ihuman Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 54.8 M | |
| Quarterly Earnings Growth Y O Y | -0.4 | |
| Forward Price Earnings | 58.1395 |
Ihuman Current Valuation Indicators
Valuation refers to the process of determining the present value of Ihuman Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Ihuman we look at many different elements of the entity such as Ihuman's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ihuman, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ihuman's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ihuman's worth.Complementary Tools for Ihuman Stock analysis
When running Ihuman's price analysis, check to measure Ihuman's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ihuman is operating at the current time. Most of Ihuman's value examination focuses on studying past and present price action to predict the probability of Ihuman's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ihuman's price. Additionally, you may evaluate how the addition of Ihuman to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |